IP Verse

Generics [uk] Limited (trading As Mylan) opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Generics [uk] Limited (trading As Mylan)

Patent Number:
EP2653873
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Jul 20, 2022
Patent Number:
EP2785702
Title:
Crystalline Dapagliflozin Hydrate
Applicant:
SANDOZ AG
Opposition Date:
Oct 22, 2020
Patent Number:
EP2371361
Title:
Methods To Mobilize Progenitor/Stem Cells
Applicant:
GENZYME CORPORATION
Opposition Date:
May 4, 2020
Patent Number:
EP2630962
Title:
Low Frequency Glatiramer Acetate Therapy
Applicant:
YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.
Opposition Date:
Mar 25, 2019
Patent Number:
EP3199172
Title:
Dosing Regimen For Multiple Sclerosis
Applicant:
YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Opposition Date:
Mar 25, 2019
Patent Number:
EP2420223
Title:
Aqueous Pharmaceutical Compositions Containing Borate-Polyol Complexes
Applicant:
ALCON RESEARCH, LTD.
Opposition Date:
Apr 19, 2018
Patent Number:
EP3000810
Title:
N3 Alkylated Benzimidazole Derivative As Mek Inhibitor
Applicant:
ARRAY BIOPHARMA, INC.
Opposition Date:
Apr 19, 2018
Patent Number:
EP2308466
Title:
Aqueous Pharmaceutical Compositions Containing Borate-Polyol Complexes
Applicant:
ALCON RESEARCH, LTD.
Opposition Date:
Feb 28, 2018
Patent Number:
EP3042646
Title:
Pharmaceutical Compositions Having Desirable Bioavailability
Applicant:
ALCON RESEARCH, LTD.
Opposition Date:
Feb 9, 2018
Patent Number:
EP2599475
Title:
Pharmaceutical Composition Having Desirable Bioavailability
Applicant:
ALCON RESEARCH, LTD.
Opposition Date:
Jan 26, 2018

Competitors of Generics [uk] Limited (trading As Mylan)

ALCON RESEARCH, LTD.

NOVARTIS AG

YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.

Want to track Generics [uk] Limited (trading As Mylan)?

Feel free to send us a message here and we will get back to you